• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.欧洲癌症与营养前瞻性调查-波茨坦研究中脂肪肝指数与2型糖尿病风险的关联。
PLoS One. 2015 Apr 22;10(4):e0124749. doi: 10.1371/journal.pone.0124749. eCollection 2015.
2
The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.脂肪肝指数与接受冠状动脉造影检查的患者死亡率升高相关。
Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1231-8. doi: 10.1016/j.numecd.2013.02.004. Epub 2013 Apr 1.
3
Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.在欧洲癌症与营养前瞻性调查-波茨坦研究中,评估各种生物标志物作为Δ5去饱和酶、Δ6去饱和酶和硬脂酰辅酶A去饱和酶活性与2型糖尿病发病之间关联的潜在介质。
Am J Clin Nutr. 2015 Jul;102(1):155-64. doi: 10.3945/ajcn.114.102707. Epub 2015 May 13.
4
Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study.在芬兰东部男性队列中,根据代谢综合征状态分析脂肪肝指数与2型糖尿病发病风险的关联:一项前瞻性研究。
BMJ Open. 2019 Jul 4;9(7):e026949. doi: 10.1136/bmjopen-2018-026949.
5
Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.非酒精性脂肪性肝病与 2 型糖尿病发病风险:循环支链氨基酸的作用。
Nutrients. 2019 Mar 26;11(3):705. doi: 10.3390/nu11030705.
6
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
7
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.在两项纵向研究中,γ-谷氨酰转移酶、脂肪肝指数与肝脏胰岛素抵抗均与高血压发病相关。
J Hypertens. 2017 Mar;35(3):493-500. doi: 10.1097/HJH.0000000000001204.
8
Breast-feeding and maternal risk of type 2 diabetes: a prospective study and meta-analysis.母乳喂养与母亲患2型糖尿病的风险:一项前瞻性研究和荟萃分析。
Diabetologia. 2014 Jul;57(7):1355-65. doi: 10.1007/s00125-014-3247-3. Epub 2014 May 1.
9
Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.在患有肥胖症的代谢健康人群中,脂肪肝指数是新发2型糖尿病的风险决定因素。
Obesity (Silver Spring). 2016 Jun;24(6):1373-9. doi: 10.1002/oby.21483. Epub 2016 Apr 26.
10
Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.多民族的美国国家健康与营养检查调查中的脂肪肝指数
Aliment Pharmacol Ther. 2015 Jan;41(1):65-76. doi: 10.1111/apt.13012. Epub 2014 Nov 6.

引用本文的文献

1
Fatty liver index and risk of type 2 diabetes of adults with normoglycemia: Insights into insulin sensitivity and beta-cell function.血糖正常的成年人的脂肪肝指数与2型糖尿病风险:对胰岛素敏感性和β细胞功能的洞察
PLoS One. 2025 Jun 26;20(6):e0327058. doi: 10.1371/journal.pone.0327058. eCollection 2025.
2
Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease Study.尿酸/高密度脂蛋白胆固醇(UA/HDL-C)是脂肪肝的可靠替代标志物吗?墨西哥人群中与代谢评分的比较评估:动脉粥样硬化疾病遗传学研究
Diagnostics (Basel). 2025 Jun 3;15(11):1419. doi: 10.3390/diagnostics15111419.
3
Two-Year Mediterranean Diet Intervention Improves Hepatic Health in MASLD Patients.两年地中海饮食干预改善代谢相关脂肪性肝病(MASLD)患者的肝脏健康。
Foods. 2025 May 14;14(10):1736. doi: 10.3390/foods14101736.
4
The mediation effect of liver and anthropometric indices on the relationship between incidence of diabetes and physical activity: results of 5-year follow up azar cohort study.肝脏和人体测量指标对糖尿病发病与体力活动关系的中介作用:azar 队列研究 5 年随访结果。
BMC Public Health. 2024 Nov 18;24(1):3190. doi: 10.1186/s12889-024-20587-6.
5
Common Denominator of MASLD and Some Non-Communicable Diseases.代谢相关脂肪性肝病(MASLD)与某些非传染性疾病的共同特征
Curr Issues Mol Biol. 2024 Jun 29;46(7):6690-6709. doi: 10.3390/cimb46070399.
6
Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis.探讨 2 型糖尿病与非酒精性脂肪性肝病之间的相互关系:遗传相关性和孟德尔随机分析。
Medicine (Baltimore). 2024 May 10;103(19):e38008. doi: 10.1097/MD.0000000000038008.
7
Carbon Dioxide (CO) Dietary Emissions Are Related to Oxidative and Inflammatory Status in Adult Population.二氧化碳(CO)膳食排放量与成年人群的氧化和炎症状态有关。
Nutrients. 2023 Dec 8;15(24):5050. doi: 10.3390/nu15245050.
8
Fatty Liver Disease in Patients with Prediabetes and Overweight or Obesity.糖尿病前期及超重或肥胖患者的脂肪肝疾病
Metabolites. 2023 Apr 7;13(4):531. doi: 10.3390/metabo13040531.
9
The association between fatty liver index and onset of diabetes: secondary analysis of a population-based cohort study.脂肪肝指数与糖尿病发病的关系:基于人群队列研究的二次分析。
BMC Public Health. 2023 Apr 11;23(1):679. doi: 10.1186/s12889-023-15442-z.
10
Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease.2 型糖尿病和/或非酒精性脂肪性肝病患者的体力活动与精细运动表现的关系。
Ann Med. 2023 Dec;55(1):1345-1353. doi: 10.1080/07853890.2023.2193422.

本文引用的文献

1
The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients.脂肪肝指数在检测和量化肥胖患者的肝脂肪变性方面效用有限。
Hepatol Int. 2013 Jun;7(2):592-9. doi: 10.1007/s12072-012-9401-4. Epub 2012 Sep 29.
2
Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.在欧洲癌症与营养前瞻性调查(EPIC)-波茨坦研究中,评估各种生物标志物作为咖啡消费与2型糖尿病发病之间关联的潜在介导因素。
Am J Clin Nutr. 2014 Sep;100(3):891-900. doi: 10.3945/ajcn.113.080317. Epub 2014 Jul 23.
3
Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis.开发、外部验证和新的肝脂肪变性诊断评分的比较评估。
Am J Gastroenterol. 2014 Sep;109(9):1404-14. doi: 10.1038/ajg.2014.155. Epub 2014 Jun 24.
4
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.世界胃肠病学组织全球指南:非酒精性脂肪性肝病和非酒精性脂肪性肝炎
J Clin Gastroenterol. 2014 Jul;48(6):467-73. doi: 10.1097/MCG.0000000000000116.
5
Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.用于诊断肝脂肪变性和胰岛素抵抗的肝脏脂肪指数比较。
PLoS One. 2014 Apr 14;9(4):e94059. doi: 10.1371/journal.pone.0094059. eCollection 2014.
6
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.非酒精性脂肪性肝病作为代谢综合征的病因和后果。
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10. doi: 10.1016/S2213-8587(14)70032-4. Epub 2014 Apr 7.
7
The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study.欧洲癌症与营养前瞻性调查(EPIC)研究中终生饮酒模式与死亡原因的关联。
Int J Epidemiol. 2013 Dec;42(6):1772-90. doi: 10.1093/ije/dyt154.
8
Assessing natural direct and indirect effects through multiple pathways.评估通过多种途径的自然直接和间接效应。
Am J Epidemiol. 2014 Feb 15;179(4):513-8. doi: 10.1093/aje/kwt270. Epub 2013 Nov 20.
9
Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.诊断脂肪肝疾病:代谢标志物、表型、基因型及已确立的生物标志物的比较评估
PLoS One. 2013 Oct 9;8(10):e76813. doi: 10.1371/journal.pone.0076813. eCollection 2013.
10
Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.队列研究非酒精性脂肪性肝病、NAFLD 纤维化评分与韩国人群中糖尿病发病风险的关系。
Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.

欧洲癌症与营养前瞻性调查-波茨坦研究中脂肪肝指数与2型糖尿病风险的关联。

Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.

作者信息

Jäger Susanne, Jacobs Simone, Kröger Janine, Stefan Norbert, Fritsche Andreas, Weikert Cornelia, Boeing Heiner, Schulze Matthias B

机构信息

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.

German Center for Diabetes Research (DZD), Neuherberg, Germany; Department of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital Tübingen, Tübingen, Germany.

出版信息

PLoS One. 2015 Apr 22;10(4):e0124749. doi: 10.1371/journal.pone.0124749. eCollection 2015.

DOI:10.1371/journal.pone.0124749
PMID:25902304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4406732/
Abstract

The fatty liver index (FLI) predicts fatty liver by using BMI, waist circumference, γ-glutamyltransferase and triglycerides. We investigated the association between the FLI and the risk of type 2 diabetes and evaluated to what extent single FLI components contribute to the diabetes risk. We analysed a case-cohort study (random sub-cohort: 1922; incident cases: 563) nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. The proportion of exposure effect (PEE) explained by single FLI components was evaluated and effect decomposition using inverse probability weighting (IPW) was applied. Women and men with a FLI ≥ 60 compared to those with a FLI < 30 had a multivariable-adjusted Hazard Ratio (HR) of 17.6; 95% confidence interval (CI) 11.1-28.0 and HR: 10.9; 95% CI 6.22-19.2, respectively. Adjustment for BMI or waist circumference attenuated this association in men [PEE BMI (95% CI) = 53.8% (43.9%-65.8%); PEE waist (95% CI) = 54.8% (44.2%-68.8%)]. In women, adjustment for waist circumference attenuated the association to a lesser degree than in men [PEE waist (95% CI) = 31.1%; (21.9%-43.1%)] while BMI had no appreciable effect [PEE BMI (95% CI) = 11.0% (2.68%-21.0%)]. γ-glutamyltransferase and triglycerides showed only a small attenuation in women [PEE GGT(95% CI) = 3.11% (-0.72%-4.48%); PEE TG (95% CI) = 6.36% (3.81%-9.92%)] and in men [PEE GGT = 0%; PEE TG (95% CI) = 6.23% (2.03%-11.8%)]. In women, the total effect was decomposed into a direct effect and 4 indirect effects (HR BMI = 1.10; HR waist = 1.28; HR GGT = 0.97 and HR TG = 1.03). In men, the 4 indirect effects were HR BMI = 1.25; HR waist = 1.29; HR GGT = 0.97 and HR TG = 0.99. These data suggest that the FLI, as a proxy for fatty liver, is associated with risk of type 2 diabetes. This association is only partly explained by standard estimates of overall and abdominal body fatness, particularly among women.

摘要

脂肪肝指数(FLI)通过使用体重指数(BMI)、腰围、γ-谷氨酰转移酶和甘油三酯来预测脂肪肝。我们研究了FLI与2型糖尿病风险之间的关联,并评估了单个FLI成分在多大程度上导致糖尿病风险。我们分析了嵌套在欧洲癌症与营养前瞻性调查(EPIC)-波茨坦研究中的一项病例队列研究(随机子队列:1922例;新发病例:563例)。评估了单个FLI成分所解释的暴露效应比例(PEE),并应用逆概率加权(IPW)进行效应分解。与FLI<30的女性和男性相比,FLI≥60的女性和男性的多变量调整风险比(HR)分别为17.6;95%置信区间(CI)为11.1-28.0和HR:10.9;95%CI为6.22-19.2。对BMI或腰围进行调整后,男性的这种关联减弱[PEE BMI(95%CI)=53.8%(43.9%-65.8%);PEE腰围(95%CI)=54.8%(44.2%-68.8%)]。在女性中,对腰围进行调整后,这种关联的减弱程度低于男性[PEE腰围(95%CI)=31.1%;(21.9%-43.1%)],而BMI没有明显影响[PEE BMI(95%CI)=11.0%(2.68%-21.0%)]。γ-谷氨酰转移酶和甘油三酯在女性[PEE GGT(95%CI)=3.11%(-0.72%-)]。在女性中,总效应被分解为直接效应和4种间接效应(HR BMI = 1.10;HR腰围 = 1.28;HR GGT = 0.97;HR甘油三酯 = 1.03)。在男性中,4种间接效应为HR BMI = 1.25;HR腰围 = 1.29;HR GGT = 0.97;HR甘油三酯 = 0.99。这些数据表明,作为脂肪肝替代指标的FLI与2型糖尿病风险相关。这种关联仅部分由总体和腹部肥胖的标准估计值解释,尤其是在女性中。 4.48%)和男性[PEE GGT = 0%;PEE甘油三酯(95%CI)=6.23%(2.03%-11.8%)]中仅显示出较小的减弱。